Solana ecosystem memecoin ASTEROID rebounds 48% intraday, while Ethereum ecosystem version faces slight pressure and pullback
BlockBeats news, on May 25, according to GMGN monitoring, the Solana ecosystem meme coin ASTEROID saw an increase this morning, with its market cap rebounding to a peak of $15.1 million before temporarily settling at $13.8 million, up 48% in 24 hours. Trading volume during the same period was relatively low at about $740,000. The current market cap is down approximately 25.9% from its all-time high.
On the Ethereum chain, ASTEROID experienced a short-term downturn in the past hour, with its lowest point nearing a market cap of $91 million. It is currently reported at around $99 million, with a 24-hour decrease of 18.6%. Trading volume over the same period exceeded $11.7 million.
According to monitoring, in the Ethereum version of ASTEROID, a trader (0x68a) conducted a large sell-off of 1.515 billion tokens (about $363,600) in the past hour, possibly putting pressure on the price. This is the largest selling address in the past 24 hours. Previously, this trader bought this token with $1.07 million and, as of press time, had sold a cumulative $829,000 position, with a total profit and loss of approximately -$136,000.
BlockBeats reminds users that meme coin trading is highly volatile and often dependent on market sentiment and concept speculation, with no actual value or use case. Investors should be aware of the risks.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y
As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
Crypto prices
More
